HEALTH CIVIL SOCIETY CALLS UPON MEMBER STATES TO SUPPORT EUROPEAN PARLIAMENT’S STRONG STAND ON HEALTH WITHIN THE EU BUDGET 2021-2027

12/04

On 1 April 2019, health civil society has published a statement calling on the Council and its Working Party on Structural Measures,…

STEP-UP 2013-2017 impact assessment report is out

08/04

Today, the European AIDS Treatment Group is publishing a report that aims to assess the impact the STEP-UP Training Academy…

Ageing with HIV Taskforce Meeting: Operationalising Ageing with HIV project R&D Outcomes and Identified Research

05/04

The European AIDS Treatment Group (EATG), held a meeting titled ‘Taskforce meeting: Operationalising Ageing with HIV project R&D Outcomes and…

Dolutegravir during pregnancy appears safe

24/04

Dolutegravir treatment does not appear to worsen pregnancy or neonatal outcomes, according to a registry study. "While the results are…

ART interruption with close monitoring, strict restart guidelines safe in HIV cure trials

24/04

Analytic treatment interruption, used to determine the efficacy of any therapeutic strategy designed to achieve antiretroviral therapy (ART)-free remission from…

ILC 2019: Hepatitis elimination by 2030 in doubt as countries fail to scale up diagnosis and treatment

24/04

Most countries will struggle to eliminate hepatitis C by 2030 due to lack of investment and political will, missing a…

HEALTH CIVIL SOCIETY CALLS UPON MEMBER STATES TO SUPPORT EUROPEAN PARLIAMENT’S STRONG STAND ON HEALTH WITHIN THE EU BUDGET 2021-2027

12/04

On 1 April 2019, health civil society has published a statement calling on the Council and its Working Party on Structural Measures,…

STEP-UP 2013-2017 impact assessment report is out

08/04

Today, the European AIDS Treatment Group is publishing a report that aims to assess the impact the STEP-UP Training Academy…

Ageing with HIV Taskforce Meeting: Operationalising Ageing with HIV project R&D Outcomes and Identified Research

05/04

The European AIDS Treatment Group (EATG), held a meeting titled ‘Taskforce meeting: Operationalising Ageing with HIV project R&D Outcomes and…

Dolutegravir during pregnancy appears safe

24/04

Dolutegravir treatment does not appear to worsen pregnancy or neonatal outcomes, according to a registry study. "While the results are…

ART interruption with close monitoring, strict restart guidelines safe in HIV cure trials

24/04

Analytic treatment interruption, used to determine the efficacy of any therapeutic strategy designed to achieve antiretroviral therapy (ART)-free remission from…

ILC 2019: Hepatitis elimination by 2030 in doubt as countries fail to scale up diagnosis and treatment

24/04

Most countries will struggle to eliminate hepatitis C by 2030 due to lack of investment and political will, missing a…